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Background: We hypothesized that intracardiac J-wave correlates with J-point amplitude on surface ECG and is augmented immediately before 
ventricular tachycardia (VT)/ventricular fibrillation (VF) in patients with structural heart disease and implantable cardioverter-defibrillator (ICD).
Methods: Baseline ECG and far-field (FF) right ventricular (RV) intracardiac ICD electrograms (EGMs) were recorded at rest in 494 patients [mean 
age 60.4 ± 13.1; 360 (72.9%) men, 463 (93.9%) primary prevention, 278 (56.3%) ischemic cardiomyopathy patients]. Ten second FF EGMs before 
the onset of arrhythmia were compared to baseline. Relative intracardiac J point amplitude was measured as the ratio of J-point amplitude to peak-
to-peak R amplitude on FF EGM. J-point amplitude was measured on baseline 12-leads surface ECG. Significant J-point elevation on surface ECG was 
diagnosed if the elevation of the QRS-ST junction (J-point) of at least 0.1 mV from baseline was detected in ≥ 2 leads, either lateral (I, aVL, V5, V6), 
or inferior (II, III, aVF).
Results: During a mean follow-up of 3.38 ± 1.86 years, 58 patients experienced sustained VT/VF (70 polymorphic PVT/VF and 213 monomorphic 
MMVT events), and 81 episodes of control spontaneous events. Distinct intracardiac J-wave was observed before PVT/VF, but not before MMVT. In 
paired t-test, relative intracardiac J-point amplitude was deviated before PVT/VF (0.28 ± 0.08 vs. -0.19 ± 0.39; p=0.012), and before MMVT (-0.02 
± 0.08 vs. -0.09 ± 0.14; p<0.0001) in comparison to baseline. Intracardiac J-point before control spontaneous events did not differ from baseline. 
Relative intracardiac J-point amplitude showed significant accuracy for PVT/VF prediction with AUC of 0.827 (95% CI 0.769-0.884). Significant 
J-point elevation on inferior ECG leads was found in 3.2% patients, and on lateral leads in 4.6% patients. Intracardiac J-point amplitude did not 
correlate with J-point amplitude on 12-leads ECG.
Conclusions: Intracardiac J-wave is augmented immediately before the onset of polymorphic VT or VF, but does not correlate with J-point 
amplitude on surface ECG. Augmented intracardiac J-wave and J-point elevation on surface ECG are likely to be 2 different entities.
